Skip to main content
Equibles
LITS logo

LITS · Lite Strategy, Inc. · Metrics

Track LITS — free

Use LITS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research LITS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.11 +0.05 (+4.72%) At close · Sep 11
Rebalance outlook locked
Market Cap
$37.77M
Shares
34.03M

LITS metrics

57 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$1.11
Market cap
$37.77M

Price action

20 metrics
Price change (1W)
+1.9%
Price change (30D)
+17.8%
Price change (3M)
+43.2%
Price change (6M)
-7.8%
Price change (YTD)
-19.7%
Price change (1Y)
-65.5%
Trailing year
Price change (5Y)
—
52-week high
$3.17
52-week low
$0.74
Change from 52-week high
-66.6%
Change from 52-week low
+43.2%
Annualized volatility
76.8%
Annualized volatility (3M)
67.0%
Beta
2.1
RSI (14D)
57.7
Price vs SMA 50
+8.3%
Price vs SMA 200
-8.3%
Avg volume (3M)
253,136
Relative volume
0.9
Average dollar volume
$242,343

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
34.03M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
0.6
reciprocal yield 157.6%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-168.6%

Historical valuation

8 metrics
P / E historical average (3Y)
1.2×
reciprocal yield 85.8%
P / E historical average (5Y)
1.2×
reciprocal yield 85.8%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
2023-11-16

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2023-09-26

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$58.09M
Net income (TTM)
−$60.82M
Trailing 12 months
Diluted EPS (TTM)
$-2.00
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$2.54

Growth

11 metrics
Revenue growth YoY
-100.0%
Year over year
Net income growth YoY
-189.7%
Revenue (TTM)
$0
Trailing 12 months
EPS growth YoY
-189.5%
Shares change YoY
+436.0%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-107.0%
Return on assets
-105.2%
Debt / equity
—
Current ratio
11.5
EBITDA (TTM)
−$58.09M
Free cash flow (TTM)
—
Quick ratio
11.5
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$7.54M
Total assets
$57.79M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$10.42M
Capital expenditures (TTM)
—
R&D (TTM)
$169,000
SG&A (TTM)
—
Stock compensation (TTM)
$866,000
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
36
13F filer change QoQ
0
Institutional ownership
19.4%

Short interest

3 metrics
Short interest
0.7%
Latest settlement · 1.4 days to cover
Days to cover
1.4d
Short-squeeze score
51 / 100

Insider activity

2 metrics
Net insider buying (90D)
$21,388
Insider-sentiment score
79 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1262104 CUSIP 55279B301 13F (30d) 23 filings 23 filers Visit website Investor relations